Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRN110755 PK Study with Food and PPI in Healthy Adults
NCT07141381Phase 1Completed
- Sponsor
- Voronoi
- Start
- Aug 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of VRN110755 in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Voronoi. Primary endpoints: Area Under the Plasma Concentration-Time Curve from Time Zero to Infinity, Maximum Observed Plasma Concentration and 2 more. Started Aug 2025; status: completed.
02
Drugs
VRN110755
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07141381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07141381.